Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02315248 · ClinicalTrials.gov registry record
Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study
A clinical trial, sponsored by University of Mississippi Medical Center.
- Completed
- Registry status
- 197
- Enrollment target
NCT02315248: Completed study, sponsored by University of Mississippi Medical Center.
NCT02315248 is a clinical trial that has completed, run by University of Mississippi Medical Center. The registered enrollment target is 197 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02315248 has completed, sponsored by University of Mississippi Medical Center.
- COMPLETED
- Registry status
- 197 participants
- Enrollment target
Study Summary
The purpose of this study is to validate a human saliva sample analyzer technique designed to screen for low bone density and osteoporosis. The analyzer technique is meant to be a simple, noninvasive, easy-to-use, cost-effective, and routine means of diagnosing bone turnover using a point-of-care device that monitors salivary markers of bone turnover in a screening patient population that is at risk for low bone density or osteoporosis.
Primary Outcome
To validate the performance of human saliva sample analyzer LFA technique against bone density as measured by quantitative computed tomography (QCT).
Interventions
- RADIATION Quantitative computed tomography scan for bone density analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2014-12 |
| Est. Completion | 2016-08 |
What the finished NCT02315248 record still lists
NCT02315248 is an observational study that tracks outcomes without assigning an intervention. The registered 197 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Quantitative computed tomography scan for bone density analysis is the first listed.
NCT02315248 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02315248 about?
NCT02315248 is a clinical study titled "Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study". The purpose of this study is to validate a human saliva sample analyzer technique designed to screen for low bone density and osteoporosis. The analyzer technique is meant to be a simple, noninvasive, easy-to-use, cost-effective, and routine means of diagnosing bone turnover using a point-of-care de...
What is the current status of trial NCT02315248?
This trial is currently completed. The enrollment target is 197 participants. The study started on 2014-12. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02315248?
The interventions under investigation include: Quantitative computed tomography scan for bone density analysis (RADIATION).
Who is sponsoring clinical trial NCT02315248?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04219254 · 197 participants · Phase 1
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
- NCT06173778 · 197 participants · Phase 2
Semaglutide for Post-Smoking Cessation Weight Management
- NCT05203328 · 198 participants · NA
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
- NCT05426967 · 198 participants · NA
rTMS for Military TBI-related Depression
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia